MAPT and Alzheimer disease: Previous research in prodromal AD found a pronounced correlation between tau PET ([18F]flortaucipir) and cortical thickness in temporal and parietal regions, whereas the correlation between amyloid PET ([18F]flutemetamol) and cortical thickness was less region specific4.